671 related articles for article (PubMed ID: 27341533)
1. LDL-C/apoB and HDL-C/apoA-1 ratios predict incident chronic kidney disease in a large apparently healthy cohort.
Bae JC; Han JM; Kwon S; Jee JH; Yu TY; Lee MK; Kim JH
Atherosclerosis; 2016 Aug; 251():170-176. PubMed ID: 27341533
[TBL] [Abstract][Full Text] [Related]
2. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort.
Mariosa D; Hammar N; Malmström H; Ingre C; Jungner I; Ye W; Fang F; Walldius G
Ann Neurol; 2017 May; 81(5):718-728. PubMed ID: 28437840
[TBL] [Abstract][Full Text] [Related]
3. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
Walldius G; Jungner I; Aastveit AH; Holme I; Furberg CD; Sniderman AD
Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein A-I, B-100, and B-48 metabolism in subjects with chronic kidney disease, obesity, and the metabolic syndrome.
Batista MC; Welty FK; Diffenderfer MR; Sarnak MJ; Schaefer EJ; Lamon-Fava S; Asztalos BF; Dolnikowski GG; Brousseau ME; Marsh JB
Metabolism; 2004 Oct; 53(10):1255-61. PubMed ID: 15375779
[TBL] [Abstract][Full Text] [Related]
5. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.
Kappelle PJ; Gansevoort RT; Hillege HJ; Wolffenbuttel BH; Dullaart RP;
J Clin Lipidol; 2013; 7(1):56-64. PubMed ID: 23351584
[TBL] [Abstract][Full Text] [Related]
6. Hierarchical modelling of blood lipids' profile and 10-year (2002-2012) all cause mortality and incidence of cardiovascular disease: the ATTICA study.
Nomikos T; Panagiotakos D; Georgousopoulou E; Metaxa V; Chrysohoou C; Skoumas I; Antonopoulou S; Tousoulis D; Stefanadis C; Pitsavos C;
Lipids Health Dis; 2015 Sep; 14():108. PubMed ID: 26370413
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
[TBL] [Abstract][Full Text] [Related]
8. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study.
Walldius G; Jungner I; Holme I; Aastveit AH; Kolar W; Steiner E
Lancet; 2001 Dec; 358(9298):2026-33. PubMed ID: 11755609
[TBL] [Abstract][Full Text] [Related]
9. Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women.
Matthan NR; Welty FK; Barrett PH; Harausz C; Dolnikowski GG; Parks JS; Eckel RH; Schaefer EJ; Lichtenstein AH
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1092-7. PubMed ID: 15087307
[TBL] [Abstract][Full Text] [Related]
10. Complementary prediction of cardiovascular events by estimated apo- and lipoprotein concentrations in the working age population. The Health 2000 Study.
Oksala N; Seppälä I; Hernesniemi J; Lyytikäinen LP; Kähönen M; Mäkelä KM; Reunanen A; Jula A; Ala-Korpela M; Lehtimäki T
Ann Med; 2013 Mar; 45(2):141-8. PubMed ID: 22524251
[TBL] [Abstract][Full Text] [Related]
11. Association of the apolipoprotein B/apolipoprotein A-I ratio and low-density lipoprotein cholesterol with insulin resistance in a Chinese population with abdominal obesity.
Ying X; Qian Y; Jiang Y; Jiang Z; Song Z; Zhao C
Acta Diabetol; 2012 Dec; 49(6):465-72. PubMed ID: 22965469
[TBL] [Abstract][Full Text] [Related]
12. Lipid profiles and risk of major adverse cardiovascular events in CKD and diabetes: A nationwide population-based study.
Lee Y; Park S; Lee S; Kim Y; Kang MW; Cho S; Park S; Han K; Kim YC; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
PLoS One; 2020; 15(4):e0231328. PubMed ID: 32271842
[TBL] [Abstract][Full Text] [Related]
13. ApoB but not LDL-cholesterol is reduced by exercise training in overweight healthy men. Results from the 1-year randomized Oslo Diet and Exercise Study.
Holme I; Høstmark AT; Anderssen SA
J Intern Med; 2007 Aug; 262(2):235-43. PubMed ID: 17645591
[TBL] [Abstract][Full Text] [Related]
14. Impact of the apolipoprotein B/apolipoprotein A-I ratio on renal outcome in immunoglobulin A nephropathy.
Lundberg S; Gunnarsson I; Jacobson SH
Scand J Urol Nephrol; 2012 Apr; 46(2):148-55. PubMed ID: 22214235
[TBL] [Abstract][Full Text] [Related]
15. Age, Sex, and Cardiovascular Risk Attributable to Lipoprotein Cholesterol Among Chinese Individuals with Coronary Artery Disease: A Case-Control Study.
Wu TT; Zheng YY; Yang YN; Li XM; Ma YT; Xie X
Metab Syndr Relat Disord; 2019 May; 17(4):223-231. PubMed ID: 30720383
[No Abstract] [Full Text] [Related]
16. Apolipoprotein B/apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men.
Wallenfeldt K; Bokemark L; Wikstrand J; Hulthe J; Fagerberg B
Stroke; 2004 Oct; 35(10):2248-52. PubMed ID: 15345795
[TBL] [Abstract][Full Text] [Related]
17. Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease.
Sniderman AD; Jungner I; Holme I; Aastveit A; Walldius G
J Intern Med; 2006 May; 259(5):455-61. PubMed ID: 16629851
[TBL] [Abstract][Full Text] [Related]
18. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
Wong ND; Chuang J; Zhao Y; Rosenblit PD
J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
[TBL] [Abstract][Full Text] [Related]
19. Association of lipid and lipoprotein profiles with future development of type 2 diabetes in nondiabetic Korean subjects: a 4-year retrospective, longitudinal study.
Seo MH; Bae JC; Park SE; Rhee EJ; Park CY; Oh KW; Park SW; Kim SW; Lee WY
J Clin Endocrinol Metab; 2011 Dec; 96(12):E2050-4. PubMed ID: 21994961
[TBL] [Abstract][Full Text] [Related]
20. The apolipoprotein B/apolipoprotein A-I ratio as a potential marker of plasma atherogenicity.
Kaneva AM; Potolitsyna NN; Bojko ER; Odland JØ
Dis Markers; 2015; 2015():591454. PubMed ID: 25852220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]